141 related articles for article (PubMed ID: 2789649)
21. Clinical manifestations of neurological involvement in primary Sjögren’s syndrome.
Gono T; Kawaguchi Y; Katsumata Y; Takagi K; Tochimoto A; Baba S; Okamoto Y; Ota Y; Yamanaka H
Clin Rheumatol; 2011 Apr; 30(4):485-90. PubMed ID: 20393864
[TBL] [Abstract][Full Text] [Related]
22. The incidence of Sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca.
Forstot JZ; Forstot SL; Greer RO; Tan EM
Arthritis Rheum; 1982 Feb; 25(2):156-60. PubMed ID: 7066046
[TBL] [Abstract][Full Text] [Related]
23. [3 cases of rare peripheral neuropathies associated with primary Gougerot-Sjögren syndrome].
Pou Serradell A; Viñas Gaya J
Rev Neurol (Paris); 1993; 149(8-9):481-4. PubMed ID: 8009146
[TBL] [Abstract][Full Text] [Related]
24. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement].
Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S
Ryumachi; 1994 Jun; 34(3):633-8. PubMed ID: 8052929
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis.
Miró J; Peña-Sagredo JL; Berciano J; Insúa S; Leno C; Velarde R
Ann Neurol; 1990 May; 27(5):582-4. PubMed ID: 2136584
[TBL] [Abstract][Full Text] [Related]
26. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
[TBL] [Abstract][Full Text] [Related]
27. Cryoglobulinemic vasculitis with primary Sjögren's syndrome: A case report.
Hasegawa J; Hayami N; Hoshino J; Suwabe T; Sumida K; Mise K; Ueno T; Yamanouchi M; Sawa N; Ohashi K; Fujii T; Takaichi K; Ubara Y
Mod Rheumatol; 2018 May; 28(3):570-574. PubMed ID: 26743943
[TBL] [Abstract][Full Text] [Related]
28. Primary Sjögren's syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis.
Ferreiro JE; Robalino BD; Saldana MJ
Am J Med; 1987 Jun; 82(6):1227-32. PubMed ID: 3605139
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.
Vitali C; Bombardieri S; Moutsopoulos HM; Coll J; Gerli R; Hatron PY; Kater L; Konttinen YT; Manthorpe R; Meyer O; Mosca M; Ostuni P; Pellerito RA; Pennec Y; Porter SR; Richards A; Sauvezie B; Schiødt M; Sciuto M; Shoenfeld Y; Skopouli FN; Smolen JS; Soromenho F; Tishler M; Wattiaux MJ
Ann Rheum Dis; 1996 Feb; 55(2):116-21. PubMed ID: 8712861
[TBL] [Abstract][Full Text] [Related]
30. [Neurologic manifestations of primary Gougerot-Sjögren syndrome].
Lafitte C
Rev Neurol (Paris); 1998 Oct; 154(10):658-73. PubMed ID: 9846336
[TBL] [Abstract][Full Text] [Related]
31. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome.
Tzioufas AG; Manoussakis MN; Costello R; Silis M; Papadopoulos NM; Moutsopoulos HM
Arthritis Rheum; 1986 Sep; 29(9):1098-104. PubMed ID: 3489468
[TBL] [Abstract][Full Text] [Related]
32. Sjögren's syndrome in patients with interstitial cystitis.
Van de Merwe J; Kamerling R; Arendsen E; Mulder D; Hooijkaas H
J Rheumatol; 1993 Jun; 20(6):962-6. PubMed ID: 8350331
[TBL] [Abstract][Full Text] [Related]
33. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
34. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
35. Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms.
Pavlakis PP; Alexopoulos H; Kosmidis ML; Mamali I; Moutsopoulos HM; Tzioufas AG; Dalakas MC
J Autoimmun; 2012 Aug; 39(1-2):27-33. PubMed ID: 22318209
[TBL] [Abstract][Full Text] [Related]
36. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
Alexander EL; Arnett FC; Provost TT; Stevens MB
Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and outcomes from the Singapore Sjögren's syndrome study.
Kam JK; Charan N; Leong RW; Loh ZW; Thong BY
Lupus; 2021 Feb; 30(2):248-255. PubMed ID: 33259751
[TBL] [Abstract][Full Text] [Related]
38. Optic Neuropathy Associated with Primary Sjögren's Syndrome: A Case Series.
Bak E; Yang HK; Hwang JM
Optom Vis Sci; 2017 Apr; 94(4):519-526. PubMed ID: 28272192
[TBL] [Abstract][Full Text] [Related]
39. Connective tissue disorders: systemic lupus erythematosus, Sjögren's syndrome, and scleroderma.
Streifler JY; Molad Y
Handb Clin Neurol; 2014; 119():463-73. PubMed ID: 24365313
[TBL] [Abstract][Full Text] [Related]
40. Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome.
Lopate G; Pestronk A; Al-Lozi M; Lynch T; Florence J; Miller T; Levine T; Rampy T; Beson B; Ramneantu I
Muscle Nerve; 2006 May; 33(5):672-6. PubMed ID: 16453296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
